In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats

Kidney International

Volumn 65, Issue 3, 2004, Pages 834-845

  Cao, Chang Chun ^b   Ding, Xiao Qiang ^a   Ou, Zhou Lou ^b   Liu, Chun Feng ^b   Peng, Li ^b   Wang, Lei ^b   Zhu, Chun Fang ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Acute renal failure; Ischemia; Nuclear factor B; Nuclear factor B decoy oligodeoxynucletides; Transfection

Indexed keywords

CREATININE; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGODEOXYNUCLEOTIDE; PROTECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RAT STRAIN; RENAL ARTERY; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1342280338     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00463.x     Document Type: Article

References (62)

1. BRADY HR, SINGER GG: Acute renal failure. Lancet 346:1533-1540, 1995
2. THADHANI R, PASCUAL M, BONVENTRE JV: Acute renal failure. N Engl J Med 334:1448-1460, 1996
3. BACK HA: Pathogenesis of acute renal failure: New aspects. Nephron 76:130-142, 1997
4. SHERIDAN AM, BONVENTRE JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9:427-434, 2000
5. RABB H, O'MEARA YM, MADERNA P, et al: Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51:1463-1468, 1997
6. RICE JC, SPENCE JS, YETMAN DL, SAFIRSTEIN RL: Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren Fail 24:703-723, 2002
7. SUNG FL, ZHU TY, AU-YEUNG KK, et al: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 62:1160-1170, 2002
8. FURUICHI K, WADA T, IWATA Y, et al: Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/ reperfusion injury in mice. Nephrol Dial Transplant 17:399-407, 2002
9. WILHELM SM, SIMONSON MS, ROBINSON AV, et al: Endothelin upregulation and localization following renal ischemia and reperfusion. Kidney Int 55:1011-1018, 1999
10. KIELAR ML, JEYARAJAH DR, ZHOU XJ, Lu CY: Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J Am Soc Nephrol 14:389-396, 2003
11. GOLIGORSKY MS, BRODSKY SV, NOIRI E: Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61:855-861, 2002
12. HALLER H, DRAGUN D, MIETHKE A, et al: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50:473-480, 1996
13. BARNES PJ, KARIN M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
14. GUIJARRO C, EGIDO J: Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59:415-424, 2001
15. LEE JL, BURCHART GJ: Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38:981-993, 1998
16. ZINGARELLI B, SHEEHAN M, WONG HR: Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 31(1 Suppl):S105-S111, 2003
17. BIELINSKA A, SHIVDASANI RA, ZHANG LQ, NABEL GJ: Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250:997-1000, 1990
18. CHO-CHUNG YS, PARK YG, LEE YN: Oligonucleotides as transcription factor decoys. Curr Opin Mol Ther 1:386-392, 1999
19. TOMITA N, MORISHITA R, HIGAKI J, OGIHARA T: A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides. Exp Nephrol 5:429-434, 1997
20. TOMITA N, MORISHITA R, LAN HY, et al: In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 11:1244-1252, 2000
21. LEE JI, BURCKART GJ: NF-kappa B: Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 38:981-993, 1998
22. MORISHITA R, SUGIMOTO T, AOKI M, et al: In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 3:894-899, 1997
23. KAWAMURA I, MORISHITA R, TSUJIMOTO S, et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 8:905-912, 2001
24. AZUMA H, TOMITA N, KANEDA Y, et al: Transfection of NF-kappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 10:415-425, 2003
25. Vos IH, GOVERS R, GRONE HJ, et al: NF-kappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 14:815-822, 2000
26. CHEN FE, HUANG DB, CHEN YQ, GHOSH G: Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 391:410-413, 1998
27. TEMPLETON NS, LASIC DD, FREDERIK PM, et al: Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15:647-652, 1997
28. Li S, RIZZO MA, BHATTACHARYA S, HUANG L: Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther 5:930-937, 1998
29. RANGAN GK, WANG Y, TAY YC, HARRIS DC: Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 56:118-134, 1999
30. CAO C, LU S, DONG C, ZHAO R: Abnormal DNA-binding of transcription factors in minimal change nephrotic syndrome. Pediatr Nephrol 16:790-795, 2001
31. HAQ M, NORMAN J, SABA SR, et al: Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 9:614-619, 1998
32. CARLUCCI GV, TEREZILA MC, SILVIA BD, et al: Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 13:2524-2533, 2002
33. AMANN K, KOCH A, HOFSTETTER J, et al: Glomerulosclerosis and progression: Effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 60:1309-1323, 2001
34. MORRISSEY JJ, KLAHR S: Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 274(3 Pt 2): F580-F586, 1998
35. TOMITA N, MORISHITA R, TOMITA S, et al: Transcription factor decoy for NF-kappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene Ther 7:1326-1332, 2000
36. LI S, HUANG L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4:891-900, 1997
37. LI B, LI S, TAN Y, et al. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 89:355-364, 2000
38. ZHU N, LIGGITT D, LIU Y, DEBS R: Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211, 1993
39. MADRY H, RESZKA R, BOHLENDER J, WAGNER J: Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo. J Mol Med 79:184-189, 2001
40. LEDLEY FD: Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum Gene Ther 6:1129-1144, 1995
41. BIRCHALL JC, KELLAWAY IW, GUMBLETON M: Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. Int J Pharm 197:221-223, 2000
42. SORGI FL, BHATTACHARYA S, HUANG L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 4: 961-968, 1997
43. MORISHITA R, GIBBONS GH, HORIUCHI M, et al. Molecular delivery system for antisense oligonucleotides: Enhanced effectiveness of antisense oligonucleotides by HVJ-liposome mediated transfer. J Cardiovasc Pharmacol Ther 2:213-222, 1997
44. DRAGUN D, TULLIUS SG, PARK JK, et al. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 54:590-602, 1998
45. CAO CC, DING XQ, OU ZL, et al. Transfection of nuclear factor-κB decoy oligodeoxynucleotides inhibits inflammatory factors expression in renal tubular epithelial cells. Chin J Nephrol (in press)
46. FAIKAH G, SONG R, JOON-KEUN P: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13:2288-2298, 2002
47. MATSUSHIMA K, LARRSEN CG, DUBOIS GC, OPPENHEIM JJ: Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485-1490, 1989
48. KRUGER B, SCHROPPEL B, ASHKAN R, et al. A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 13:2585-2589, 2002
49. CORSI MM, LEONE G, FULGENZI A, et al. RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure. Clin Biochem 32:455-460, 1999
50. RICE JC, SPENCE JS, YETMAN DL, SAFIRSTEIN RL: Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren Fail 24:703-723, 2002
51. ROVIN BH, DICKERSON JA, TAN LC, HEBERT CA: Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int 48:1263-1271, 1995
52. KELLY KJ, WILLIAMS WW JR, COLVIN RB, BONVENTRE JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816, 1994
53. MOLITORIS BA, MARRS J: The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106:583-592, 1999
54. GRACE PA: Ischemia-reperfusion injury. Br J Surg 81:637-647, 1994
55. YU L, GENGARO PE, NIEDERBERGER M, et al: Nitric oxide: A mediator in tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 91:1691-1695, 1994
56. YANAGISAWA M, KURIHARA H, KIMURA S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
57. NORD EP: Renal actions of endothelin. Kidney Int 44:451-463, 1993
58. SCHWARTZ IF, SCHWARTZ D, TRASKONOV M, et al: L-Arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats. Kidney Int 62:1700-1706, 2002
59. LING H, EDELSTEIN C, GENGARO P, et al: Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 277:F383-F390, 1999
60. XIE Q, NATHAN C: The high-output nitric oxide pathway: Role and regulation. J Leukoc Biol 56:576-582, 1994
61. NOIRI E, PERESLENI T, MILLER F: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 61:2377-2383, 1996
62. KAKOKI M, HIRATA Y, HAYAKAWA H, et al: Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 11:301-309, 2000